Signal active
Organization
Contact Information
Overview
NanoDx is a medical device start-up company commercializing easy-to-use, low-cost, handheld point-of-care products for the screening and monitoring of mild brain injury. It is redefining the identification and management of concussions which represent reported brain injuries.
About
Biotechnology, Health Care, Medical Device
2010
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
NanoDx headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $3.2B in funding across 84 round(s). With a team of 11-50 employees, NanoDx is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - NanoDx, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
7
0
0
$37.9M
Details
3
NanoDx has raised a total of $37.9M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Late Stage Venture | 18.0M | ||
2016 | Early Stage Venture | 4.0M | ||
2013 | Early Stage Venture | 4.0M |
Investors
NanoDx is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
NanoDx | - | FUNDING ROUND - NanoDx | 2.0M |
MedScience Ventures | - | FUNDING ROUND - MedScience Ventures | 2.0M |
NanoDx | - | FUNDING ROUND - NanoDx | 4.0M |
Provident Healthcare Capital | - | FUNDING ROUND - Provident Healthcare Capital | 4.0M |
Recent Activity
There is no recent news or activity for this profile.